Bower L, Manley G
J Clin Pathol. 1981 Oct;34(10):1097-101. doi: 10.1136/jcp.34.10.1097.
Urinary glycosaminoglycan and hydroxyproline excretion was studied in 11 patients with clear evidence of Paget's disease of bone. Urinary hydroxyproline, cetyl pyridinium chloride (CPC)-precipitable uronic acid and CPC-precipitable hexosamine were expressed as ratios to urinary creatinine. Urine samples were concentrated x 1000 by vacuum dialysis and the glycosaminoglycans examined by electrophoresis on cellulose acetate followed by staining with alcian blue. All the cases studied showed markedly raised hydroxyproline excretion, whereas the uronic acid excretion was normal or only slightly raised in 10 of the 11 cases studied. One patient who had a raised uronic acid and raised hydroxyproline concentration was shown to have osteosarcoma as a complication of Paget's disease. THE VERY HIGH HYDROXYPROLINE: creatinine ratio in all cases of Paget's disease (mean 241.8 mmol hydroxyproline/mol creatinine) contrasted sharply with the cases of disseminated neoplasm, where the ratio was either normal or slightly raised (mean 29.3 mmol hydroxyproline/mol creatinine). The ratio of hydroxyproline to CPC-precipitable uronic acid was also markedly raised in cases of Paget's disease (mean 77.3 mmol hydroxyproline/mmol uronic acid) and was lower in the neoplastic group (mean 14.1 mmol hydroxyproline/mmol uronic acid) but showed no advantage over the hydroxyproline: creatinine ratio in differentiating the two groups. THE URINARY HYDROXYPROLINE: creatinine ratio promises to be of value in differentiating between Paget's disease of bone and neoplastic invasion of bone. A marked rise in CPC-precipitable uronic acid excretion alone is more suggestive of neoplastic invasion of bone, and if associated with a marked increase in hydroxyproline excretion, it raises the possibility of neoplastic change in Paget's disease of bone. The results of this study also suggest that bone collagen, rather than bone tissue in general, is primarily affected in Paget's disease.
对11例有明确骨Paget病证据的患者进行了尿糖胺聚糖和羟脯氨酸排泄情况的研究。尿羟脯氨酸、十六烷基氯化吡啶(CPC)沉淀的糖醛酸和CPC沉淀的己糖胺均以与尿肌酐的比值表示。尿液样本通过真空透析浓缩1000倍,然后将糖胺聚糖在醋酸纤维素上进行电泳,接着用阿尔辛蓝染色来检测。所有研究病例均显示羟脯氨酸排泄显著升高,而在11例研究病例中的10例,其糖醛酸排泄正常或仅略有升高。1例糖醛酸和羟脯氨酸浓度均升高的患者被证明患有骨肉瘤,这是骨Paget病的一种并发症。骨Paget病所有病例中羟脯氨酸与肌酐的比值非常高(平均241.8 mmol羟脯氨酸/摩尔肌酐),这与播散性肿瘤病例形成鲜明对比,后者该比值正常或略有升高(平均29.3 mmol羟脯氨酸/摩尔肌酐)。骨Paget病病例中羟脯氨酸与CPC沉淀的糖醛酸的比值也显著升高(平均77.3 mmol羟脯氨酸/毫摩尔糖醛酸),而在肿瘤组中该比值较低(平均14.1 mmol羟脯氨酸/毫摩尔糖醛酸),但在区分这两组时,该比值并不比羟脯氨酸与肌酐的比值更具优势。尿羟脯氨酸与肌酐的比值有望在区分骨Paget病和骨肿瘤浸润方面具有价值。仅CPC沉淀的糖醛酸排泄显著升高更提示骨肿瘤浸润,如果再伴有羟脯氨酸排泄显著增加,则增加了骨Paget病发生肿瘤性改变的可能性。本研究结果还表明,在骨Paget病中主要受影响的是骨胶原,而非一般的骨组织。